Ingrid Kane
Directeur Technique/Scientifique/R&D chez SIGHT SCIENCES, INC.
Profil
Ingrid Kane is currently the Vice President-Global Medical Affairs at Sight Sciences, Inc. Previously, she worked as the Vice President-Medical Affairs at iScience Interventional Corp.
She holds a doctorate degree from the University of Charles.
Postes actifs de Ingrid Kane
| Sociétés | Poste | Début |
|---|---|---|
| SIGHT SCIENCES, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Ingrid Kane
| Sociétés | Poste | Fin |
|---|---|---|
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Ingrid Kane
| University of Charles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIGHT SCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |